These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 19944137)
1. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. Dahan A; Amidon GL Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137 [TBL] [Abstract][Full Text] [Related]
2. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related]
3. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. Dahan A; Sabit H; Amidon GL Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874 [TBL] [Abstract][Full Text] [Related]
4. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport. Dahan A; Sabit H; Amidon GL AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690 [TBL] [Abstract][Full Text] [Related]
5. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Liang E; Proudfoot J; Yazdanian M Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220 [TBL] [Abstract][Full Text] [Related]
7. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein. Dahan A; Amidon GL Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359 [TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification. Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Incecayir T; Tsume Y; Amidon GL Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720 [TBL] [Abstract][Full Text] [Related]
11. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222 [TBL] [Abstract][Full Text] [Related]
12. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. Xiao L; Yi T; Chen M; Lam CW; Zhou H Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020 [TBL] [Abstract][Full Text] [Related]
13. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells. Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448 [TBL] [Abstract][Full Text] [Related]
14. Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum. Flanagan SD; Benet LZ Pharm Res; 1999 Feb; 16(2):221-24. PubMed ID: 10100306 [TBL] [Abstract][Full Text] [Related]
15. Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters. Cholkar K; Trinh HM; Vadlapudi AD; Wang Z; Pal D; Mitra AK J Ocul Pharmacol Ther; 2015 May; 31(4):248-55. PubMed ID: 25844889 [TBL] [Abstract][Full Text] [Related]
16. Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter. Sawangrat K; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A J Pharm Sci; 2018 Nov; 107(11):2946-2956. PubMed ID: 30053556 [TBL] [Abstract][Full Text] [Related]
17. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Zhou W; Di LQ; Wang J; Shan JJ; Liu SJ; Ju WZ; Cai BC Acta Pharmacol Sin; 2012 Aug; 33(8):1069-79. PubMed ID: 22773077 [TBL] [Abstract][Full Text] [Related]
18. Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza. Yu XY; Zhou ZW; Lin SG; Chen X; Yu XQ; Liang J; Duan W; Wen JY; Li XT; Zhou SF Xenobiotica; 2007 Apr; 37(4):375-415. PubMed ID: 17455112 [TBL] [Abstract][Full Text] [Related]
19. Intestinal absorption mechanisms of araloside A in situ single-pass intestinal perfusion and in vitro Caco-2 cell model. Yang H; Zhai B; Fan Y; Wang J; Sun J; Shi Y; Guo D Biomed Pharmacother; 2018 Oct; 106():1563-1569. PubMed ID: 30119231 [TBL] [Abstract][Full Text] [Related]
20. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]